Inhibiting Pathways Predicted From a Steroid Hormone Gene Signature Yields Synergistic Antitumor Effects in NSCLC-Reference-Cited by-同舟云学术

Inhibiting Pathways Predicted From a Steroid Hormone Gene Signature Yields Synergistic Antitumor Effects in NSCLC

Published:2020-01 Issue:1 Volume:15 Page:62-79
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Almotlak Abdulaziz A.,Farooqui Mariya,Siegfried Jill M.

Funder

University of Minnesota

Masonic Cancer Center, University of Minnesota

SACM

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference51 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome;Stabile;Clin Cancer Res,2011

3. Human non–small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen;Stabile;Cancer Res,2002

4. Aromatase expression predicts survival in women with early-stage non–small cell lung cancer;Mah;Cancer Res,2007

5. Regulation of endogenous gene expression in human non–small cell lung cancer cells by estrogen receptor ligands;Hershberger;Cancer Res,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell transcriptome analysis reveals dynamic changes of the preclinical A549 cancer models, and the mechanism of dacomitinib;European Journal of Pharmacology;2023-12

2. Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer;Frontiers in Oncology;2023-08-28

3. Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice;Frontiers in Pharmacology;2023-04-07

4. Expression patterns and clinical significance of estrogen receptor in non-small cell lung cancer;Pathology - Research and Practice;2023-01

5. Targeting the ERβ/HER Oncogenic Network in KRAS Mutant Lung Cancer Modulates the Tumor Microenvironment and Is Synergistic with Sequential Immunotherapy;International Journal of Molecular Sciences;2021-12-22